Online study on digital tools for HIV prevention and treatment in Brazil
Part of Immune system & allergy, Infections clinical trials.
This study tests online programs to help people who are at higher risk for HIV get prevention or treatment. It aims to see if digital tools can improve access to and use of HIV medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Assigned male at birth and identify as a man, travesti, transgender, or non-binary
- 18 years or older
- Residing in Brazil
- Have internet access
- Reported sex with a man in the last 12 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps people at higher risk of HIV get access to PrEP, a daily medication that prevents HIV infection. The program focuses on underserved communities in Rio de Janeiro and aims to make PrEP easier to access and use.
This study tests a program to help people living with HIV who have difficulty taking their medications consistently. The goal is to see if extra support can improve health outcomes.
This trial tests a text-messaging program to help young guys who have sex with guys stay HIV-negative. It's designed for teens and young adults who own a cell phone and can take a quick HIV test at home.
This study tests whether special “U=U” style messages can improve how men move from HIV testing to starting treatment and continuing care. You may be asked to receive guidance and information meant to help you stay engaged in HIV treatment.
This study tests if getting HIV prevention medication (PrEP) from a trained peer in your community works as well as getting it from a clinic. It is for young people aged 15 to 24 who are sexually active and not yet using PrEP.
This trial tests an mHealth (phone-based) program to help women with HIV improve health outcomes. It targets people who have had recent challenges with clinic visits, detectable virus levels, or taking HIV medicines.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.